Vif Substitution Enables Persistent Infection of Pig-Tailed Macaques by Human Immunodeficiency Virus Type 1

被引:32
|
作者
Thippeshappa, Rajesh [1 ]
Polacino, Patricia [5 ]
Kimata, Monica T. Yu [1 ]
Siwak, Edward B. [1 ]
Anderson, David [5 ]
Wang, Weiming [3 ]
Sherwood, Laura [2 ]
Arora, Reetakshi [1 ]
Wen, Michael [3 ]
Zhou, Paul [3 ]
Hu, Shiu-Lok [4 ,5 ]
Kimata, Jason T. [1 ]
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX 78227 USA
[3] Chinese Acad Sci, Inst Pasteur Shanghai, Antiviral Immun & Gene Therapy Unit, Shanghai 200025, Peoples R China
[4] Univ Washington, Dept Pharmaceut, Seattle, WA 98121 USA
[5] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98121 USA
关键词
HIV-1 REVERSE TRANSCRIPTION; BLOOD MONONUCLEAR-CELLS; FUSION INHIBITOR T-20; CD4(+) T-CELLS; MACACA-NEMESTRINA; CYTIDINE DEAMINASE; ACCESSORY PROTEINS; HUMAN APOBEC3G; NEUTRALIZING ANTIBODY; PIGTAILED MACAQUES;
D O I
10.1128/JVI.02438-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Among Old World monkeys, pig-tailed macaques (Pt) are uniquely susceptible to human immunodeficiency virus type 1 (HIV-1), although the infection does not persist. We demonstrate that the susceptibility of Pt T cells to HIV-1 infection is due to the absence of postentry inhibition by a TRIM5 isoform. Notably, substitution of the viral infectivity factor protein, Vif, with that from pathogenic SIVmne enabled replication of HIV-1 in Pt T cells in vitro. When inoculated into juvenile pig-tailed macaques, the Pt-tropic HIV-1 persistently replicated for more than 1.5 to 2 years, producing low but measurable plasma viral loads and persistent proviral DNA in peripheral blood mononuclear cells. It also elicited strong antibody responses. However, there was no decline in CD4(+) T cells or evidence of disease. Surprisingly, the Pt-tropic HIV-1 was rapidly controlled when inoculated into newborn Pt macaques, although it transiently rebounded after 6 months. We identified two notable differences between the Pt-tropic HIV-1 and SIVmne. First, SIV Vif does not associate with Pt-tropic HIV-1 viral particles. Second, while Pt-tropic HIV-1 degrades both Pt APOBEC3G and APOBEC3F, it prevents their inclusion in virions to a lesser extent than pathogenic SIVmne. Thus, while SIV Vif is necessary for persistent infection by Pt-tropic HIV-1, improved expression and inhibition of APOBEC3 proteins may be required for robust viral replication in vivo. Additional adaptation of the virus may also be necessary to enhance viral replication. Nevertheless, our data suggest the potential for the pig-tailed macaque to be developed as an animal model of HIV-1 infection and disease.
引用
收藏
页码:3767 / 3779
页数:13
相关论文
共 49 条
  • [21] Development and Assessment of a Multiplex Real-Time PCR Assay for Quantification of Human Immunodeficiency Virus Type 1 DNA
    Beloukas, A.
    Paraskevis, D.
    Haida, C.
    Sypsa, V.
    Hatzakis, A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (07) : 2194 - 2199
  • [22] Amino acid and peptide esters of abacavir: synthesis and activity against human immunodeficiency virus type 1 in cell culture
    Stankova, Ivanka
    Stanoeva, Kamelia
    Hinkov, Anton
    Alexiev, Ivailo
    Genova-Kalou, Petya
    Chayrov, Radoslav
    Argirova, Radka
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (12) : 4053 - 4059
  • [23] Host Restriction Factors APOBEC3G/3F and Other Interferon-Related Gene Expressions Affect Early HIV-1 Infection in Northern Pig-Tailed Macaque (Macaca leonina)
    Pang, Wei
    Song, Jia-Hao
    Lu, Ying
    Zhang, Xiao-Liang
    Zheng, Hong-Yi
    Jiang, Jin
    Zheng, Yong-Tang
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [24] RETRACTED: Characterization of long-term survivors of human immunodeficiency virus type 1 infection (Retracted article. See vol 64, U5, 1998)
    Cao, YZ
    Qin, LM
    Zhang, LQ
    Safrit, J
    Ho, DD
    IMMUNOLOGY LETTERS, 1996, 51 (1-2) : 7 - 13
  • [25] Human Cytomegalovirus Enhances Placental Susceptibility and Replication of Human Immunodeficiency Virus Type 1 (HIV-1), Which May Facilitate In Utero HIV-1 Transmission
    Johnson, Erica L.
    Boggavarapu, Sahithi
    Johnson, Elan S.
    Lal, Asim A.
    Agrawal, Parth
    Bhaumik, Siddhartha Kumar
    Murali-Krishna, Kaja
    Chakraborty, Rana
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (09): : 1464 - 1473
  • [26] Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome
    Barbosa, Jeremy A. Ferreira
    Sparapani, Samantha
    Boulais, Jonathan
    Lodge, Robert
    Cohen, Eric A.
    JOURNAL OF VIROLOGY, 2021, 95 (15)
  • [27] APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo
    Kourteva, Yordanka
    De Pasquale, MariaPia
    Allos, Tara
    McMunn, Chara
    D'Aquila, Richard T.
    VIROLOGY, 2012, 430 (01) : 1 - 9
  • [28] Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions
    Cervantes-Acosta, G
    Lodge, R
    Lemay, G
    Cohen, EA
    JOURNAL OF HUMAN VIROLOGY, 2001, 4 (05) : 249 - 259
  • [29] Current Perspectives in Human T-Cell Leukemia Virus Type 1 Infection and Its Associated Diseases
    Miura, Michi
    Naito, Tadasuke
    Saito, Mineki
    FRONTIERS IN MEDICINE, 2022, 9
  • [30] Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments
    Hone, DM
    DeVico, A
    Fouts, TR
    Onyabe, DY
    Agwale, SM
    Wambebe, CO
    Blattner, WA
    Gallo, RC
    Lewis, GK
    JOURNAL OF HUMAN VIROLOGY, 2002, 5 (01) : 17 - 23